Year |
Citation |
Score |
2022 |
Breviario S, Senserrich J, Florensa-Zanuy E, Garro-Martínez E, Díaz Á, Castro E, Pazos Á, Pilar-Cuéllar F. Brain matrix metalloproteinase-9 activity is altered in the corticosterone mouse model of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 120: 110624. PMID 36038021 DOI: 10.1016/j.pnpbp.2022.110624 |
0.512 |
|
2021 |
Garro-Martínez E, Fullana MN, Florensa-Zanuy E, Senserrich J, Paz V, Ruiz-Bronchal E, Adell A, Castro E, Díaz Á, Pazos Á, Bortolozzi A, Pilar-Cuéllar F. mTOR Knockdown in the Infralimbic Cortex Evokes A Depressive-like State in Mouse. International Journal of Molecular Sciences. 22. PMID 34445375 DOI: 10.3390/ijms22168671 |
0.542 |
|
2021 |
Amigo J, Garro-Martinez E, Vidal Casado R, Compan V, Pilar-Cuéllar F, Pazos A, Díaz A, Castro E. 5-HT Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression. Acs Chemical Neuroscience. PMID 33974408 DOI: 10.1021/acschemneuro.1c00158 |
0.576 |
|
2021 |
Florensa-Zanuy E, Garro-Martínez E, Adell A, Castro E, Díaz Á, Pazos Á, Mac-Dowell KS, Martín-Hernández D, Pilar-Cuéllar F. Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: modulation of inflammatory pathways. Biochemical Pharmacology. 114433. PMID 33513342 DOI: 10.1016/j.bcp.2021.114433 |
0.551 |
|
2019 |
Garro-Martínez E, Vidal R, Adell A, Díaz Á, Castro E, Amigó J, Gutiérrez-Lanza R, Florensa-Zanuy E, Gómez-Acero L, Taketo MM, Pazos Á, Pilar-Cuéllar F. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System. Molecular Neurobiology. PMID 31823197 DOI: 10.1007/s12035-019-01841-0 |
0.541 |
|
2019 |
Pilar-Cuellar F, Castro E, Bretin S, Mocaer E, Pazos Á, Díaz Á. S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30980840 DOI: 10.1016/j.pnpbp.2019.04.005 |
0.523 |
|
2018 |
Ibarra-Lecue I, Pilar-Cuéllar F, Muguruza C, Florensa-Zanuy E, Díaz Á, Urigüen L, Castro E, Pazos A, Callado LF. The endocannabinoid system in mental disorders: Evidence from human brain studies. Biochemical Pharmacology. PMID 30026022 DOI: 10.1016/j.bcp.2018.07.009 |
0.474 |
|
2018 |
Vidal R, Garro-Martínez E, Díaz Á, Castro E, Florensa-Zanuy E, Taketo MM, Pazos Á, Pilar-Cuéllar F. Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation. Molecular Neurobiology. PMID 29737454 DOI: 10.1007/s12035-018-1100-2 |
0.497 |
|
2017 |
Pilar-Cuellar F, Vidal Casado R, Diaz A, Garro-Martinez E, Linge R, Castro E, Haberzettl R, Fink H, Bert B, Brosda J, Romero B, Crespo Facorro B, Pazos A. Enhanced stress response in 5-HT1AR overexpressing mice: altered HPA function and hippocampal long-term potentiation. Acs Chemical Neuroscience. PMID 28777913 DOI: 10.1021/acschemneuro.7b00156 |
0.489 |
|
2016 |
Jiménez-Sánchez L, Linge R, Campa L, Valdizán EM, Pazos Á, Díaz Á, Adell A. Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex. Neuropharmacology. PMID 27108934 DOI: 10.1016/j.neuropharm.2016.04.020 |
0.506 |
|
2015 |
Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology. 103: 16-26. PMID 26711860 DOI: 10.1016/j.neuropharm.2015.12.017 |
0.581 |
|
2013 |
Vidal R, Diaz A, Pazos A, Castro E. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment. Psychopharmacology. 229: 177-85. PMID 23609771 DOI: 10.1007/s00213-013-3104-y |
0.547 |
|
2011 |
Vidal R, Pilar-Cuéllar F, dos Anjos S, Linge R, Treceño B, Vargas VI, Rodriguez-Gaztelumendi A, Mostany R, Castro E, Diaz A, Valdizán EM, Pazos A. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways. Current Pharmaceutical Design. 17: 521-33. PMID 21375480 DOI: 10.2174/138161211795164086 |
0.663 |
|
2003 |
Castro M, Diaz A, del Olmo E, Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology. 44: 93-101. PMID 12559126 DOI: 10.1016/S0028-3908(02)00340-4 |
0.643 |
|
2001 |
Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M. Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. Journal of Chemical Neuroanatomy. 21: 63-73. PMID 11173221 DOI: 10.1016/S0891-0618(00)00092-2 |
0.3 |
|
2000 |
Sanchez MD, Milanés MV, Pazos A, Diaz A, Laorden ML. Autoradiographic evidence of delta-opioid receptor downregulation after prenatal stress in offspring rat brain. Pharmacology. 60: 13-8. PMID 10629438 |
0.48 |
|
1996 |
Sanchez MD, Milanés MV, Pazos A, Diaz A, Laorden ML. Autoradiographic evidence of mu-opioid receptors down-regulation after prenatal stress in offspring rat brain. Brain Research. Developmental Brain Research. 94: 14-21. PMID 8816272 DOI: 10.1016/0165-3806(96)00032-6 |
0.483 |
|
1995 |
Diaz A, Ruiz F, Flórez J, Hurlé MA, Pazos A. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. The Journal of Pharmacology and Experimental Therapeutics. 274: 1545-51. PMID 7562532 |
0.459 |
|
Show low-probability matches. |